| |
BioReliance Appoints Executive Chairman to be Interim CEO and Announces
Recent Senior Executive Additions
BioReliance Corporation has appointed its Executive Chairman, Charles C.
Harwood, Jr., to the additional post of Interim CEO, following the
announced resignation of Tim Derrington from the CEO position. In
addition, BioReliance announced that three senior executives have joined
the company since June: David E. Onions, Ph.D., as Chief Scientific
Officer, David S. Walker as Chief Financial Officer, and Darryl L. Goss
as Vice President of Global Process Excellence.
Click here to read the
press release.
|
|
|
|
|
Welcome to BioReliance!
|
BioReliance is the world's largest specialist provider of contract biologics safety testing, GMP manufacturing and pre-clinical and clinical testing services. We have a number of exciting opportunities and welcome general applications with a resume from qualified individuals who may be interested in pursuing current or future opportunities within BioReliance worldwide. BioReliance is an Equal Opportunity Employer and offers a comprehensive benefits package.
|  |
|
|
